Clinical trial
Prospective Observational Study of Polypharmacy, Safety, and Medication Adherence in Patients With HFrEF and HFmrEF: Data From the FARAON Registry
NCT07640854 is registered in ClinicalTrials.gov with National Medical Research Center for Therapy and Preventive Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study of Polypharmacy, Safety, and Medication Adherence in Patients With HFrEF and HFmrEF: Data From the FARAON Registry
- Lead sponsor
- National Medical Research Center for Therapy and Preventive Medicine
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 20, 2026
- Completion date
- January 31, 2027
- Enrollment
- 130 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure with reduced and mildly reduced ejection fraction (hfref and hfmref)